Biotech

All Articles

Amgen records first stage 3 win for $400M dermatitis medicine

.Amgen has shared (PDF) the very first phase 3 information on its $400 million dermatitis medication...

Biogen, UCB document stage 3 lupus gain after falling short earlier test

.Biogen and UCB's gamble on advancing into period 3 astride a broken research study hopes to have ac...

Aptadir really hopes brand new RNA inhibitors may turn around difficult cancers

.Italian biotech Aptadir Therapies has released along with the promise that its own pipeline of prec...

Wave surfs DMD success to regulators' doors, sending out stockpile

.Surge Lifestyle Sciences has actually met its own target in a Duchenne muscular dystrophy (DMD) stu...

Sanofi plucks brand new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer,...

Achilles droplets cell therapy course, prepares for layoffs after missing 'office stability' objectives

.Achilles Rehabs has torn up its own technique. The British biotech is knocking off on its own clini...

Aligos trumpets phase 2 MASH win, slashing liver fat up to 46%

.Aligos Therapies is actually trumpeting a midstage win in metabolic-dysfunction affiliated steatohe...

Basilea ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building new antifungals has obtained a significant improvement from t...

Capricor offers Europe legal rights to late-stage DMD treatment for $35M

.Possessing actually scooped up the U.S. rights to Capricor Rehabs' late-stage Duchenne muscle dystr...

FDA scraps adcomm for Applied's rare ailment medication

.After dismissing the decision meeting for Applied Rehabs' metabolic disorder drug govorestat, the F...